epocrates logo
epocrates logo
epocrates logo
  • 0
Internally Generated Content

epocrates

Withdrawn FDA approval - oxandrolone

August 9, 2023

card-image

oxandrolone - withdrawn from market due to safety concerns and risk/benefit ratio.

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information